Podcast appearances and mentions of marty makary

"The average marketplace deductible grew by about $1,000 per person in 2026. Premium payments increased by an average of 58%... We might be seeing the death throes of the fully insured market."Welcome back to Last Month in Healthcare! This month, Spencer, Nathaniel, and special guest Jonathan Lopez break down the most impactful healthcare headlines and regulatory shifts from May 2026.The episode kicks off with a discussion on the sudden resignation of FDA Commissioner Dr. Marty Makary following reported clashes with the food, tobacco, and pharmaceutical industries. From there, the guys dive into the shocking 58% premium hikes and 37% deductible increases hitting the ACA marketplace as carriers like Cigna exit the space.Finally, Spencer and Jonathan play a World Cup-themed game guessing the cost of medical procedures across different North American cities and answer a listener question about Cost Plus Drugs and the rise of direct-to-consumer pharmacy models.If you'd like your question answered on next month's episode, call/text 469-213-6381 and leave us a voicemail/text.Thank you to our sponsor, Walk On Clinic. This month, we shared a tragic reminder to our listeners on the critical importance of early cancer detection and proactive primary care. To hear Chris's brother-in-law's music, tune in here: https://open.spotify.com/artist/1SKw4DO9FNLjcZDb5Q81q4?si=Dwpuz2wOTRawhMDfR5NIsAEpisode Chapters:(00:00:00) Intro: The Importance of Early Detection & Walk-On Clinic(00:02:30) Dr. Marty Makary Resigns as FDA Commissioner(00:04:37) ACA Marketplace Premiums Skyrocket by 58%(00:07:51) HR 8163: Stopping the Squeeze on Physician Reimbursements(00:12:34) Harvard Study: AI Outperforms Doctors in ER Triage(00:14:53) The FDA's Push for Hospital-at-Home Devices(00:17:18) Game: Guess the Procedure Cost (World Cup Edition)(00:21:22) Ask Spencer Anything: Cost Plus Drugs & D2C Pharmacies

"The average marketplace deductible grew by about $1,000 per person in 2026. Premium payments increased by an average of 58%... We might be seeing the death throes of the fully insured market."Welcome back to Last Month in Healthcare! This month, Spencer, Nathaniel, and special guest Jonathan Lopez break down the most impactful healthcare headlines and regulatory shifts from May 2026.The episode kicks off with a discussion on the sudden resignation of FDA Commissioner Dr. Marty Makary following reported clashes with the food, tobacco, and pharmaceutical industries. From there, the guys dive into the shocking 58% premium hikes and 37% deductible increases hitting the ACA marketplace as carriers like Cigna exit the space.Finally, Spencer and Jonathan play a World Cup-themed game guessing the cost of medical procedures across different North American cities and answer a listener question about Cost Plus Drugs and the rise of direct-to-consumer pharmacy models.If you'd like your question answered on next month's episode, call/text 469-213-6381 and leave us a voicemail/text.Thank you to our sponsor, Walk On Clinic. This month, we shared a tragic reminder to our listeners on the critical importance of early cancer detection and proactive primary care. To hear Chris's brother-in-law's music, tune in here: https://open.spotify.com/artist/1SKw4DO9FNLjcZDb5Q81q4?si=Dwpuz2wOTRawhMDfR5NIsAEpisode Chapters:(00:00:00) Intro: The Importance of Early Detection & Walk-On Clinic(00:02:30) Dr. Marty Makary Resigns as FDA Commissioner(00:04:37) ACA Marketplace Premiums Skyrocket by 58%(00:07:51) HR 8163: Stopping the Squeeze on Physician Reimbursements(00:12:34) Harvard Study: AI Outperforms Doctors in ER Triage(00:14:53) The FDA's Push for Hospital-at-Home Devices(00:17:18) Game: Guess the Procedure Cost (World Cup Edition)(00:21:22) Ask Spencer Anything: Cost Plus Drugs & D2C Pharmacies

The FDA is bleeding out Covid contrarians. Marty Makary, Vinay Prasad, Tracy Beth Høeg—all gone. Jonathan Howard returns to discuss why so many RFK Jr's friends have reached the end of their bureaucratic road. Show Notes FDA Swaps Top Drug and Vaccine Regulators in Staff Overhaul F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure No One Should Care About or Trust Anything Dr. Marty Makary Says Ever Again My Sincere Message to Dr. Jay Bhattacharya: Welcome Aboard and Good Luck. We Are Rooting for Your Success. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this week's episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl probe the facts beneath healthcare's biggest headlines. Today's show examines the accelerating progress of generative AI, the political turmoil inside America's leading health agencies and the infectious disease threats testing the nation's public health readiness. The conversation opens with a listener question about how close generative AI is to matching clinicians. Dr. Pearl explains that the technology is advancing faster than he predicted in ChatGPT, MD, with recent research showing an OpenAI model outperforming experienced physicians on emergency room triage and management in text-based clinical cases. He cautions that medicine is more complicated than written scenarios but argues that the trajectory is clear: before today's incoming medical students finish training, generative AI tools are likely to be used in emergency rooms across the country From there, the episode turns to the resignation of former FDA commissioner and Dr. Marty Makary, a two-time Fixing Healthcare guest. Pearl describes Makary as a respected clinician and patient-safety expert who found himself caught between scientific rigor, political pressure, industry opposition and public health critics. His departure, along with other leadership upheaval at FDA, CDC, NIH and HHS, raises a larger concern about whether America's once-trusted scientific agencies can regain their independence and credibility. Here are the other major storylines from episode 107: RFK Jr. removes preventive-care leaders. Pearl criticizes the firing of two respected co-chairs of the U.S. Preventive Services Task Force, warning that prevention policy may be pushed away from scientific evidence. The surgeon general nomination moving toward confirmation. Nicole Safier appears more confirmable than Dr. Casey Means because her vaccine views are closer to the scientific mainstream. A hantavirus outbreak raises public health concerns. A cruise ship outbreak involving the Andes virus appears to have spread person-to-person, causing at least 13 cases, several severe illnesses and three deaths. The U.S. remains vulnerable to fast-moving outbreaks. Pearl says the slow federal response to hantavirus shows how weakened public health capacity could become dangerous if a highly lethal virus were also easily transmissible. Tick bites are rising sharply. ER visits related to tick bites have climbed well above typical levels, driven in part by warmer temperatures and the spread of deer ticks into the Midwest and South. Ebola exposes the cost of global health cuts. A new Ebola strain in the Democratic Republic of Congo has no vaccine or effective treatment, and the outbreak was recognized only after spreading for weeks. USAID and WHO cuts increase risk to Americans. Pearl argues that reducing global public health support does not put “America first” because viruses ignore national borders. Patients should be more concerned when doctors avoid AI entirely. Pearl says he would worry more about clinicians who refuse to use reliable generative AI tools than those who consult them regularly. Opioid overdose deaths are falling but remain devastating. New CDC data show overdose deaths down for the third straight year, but annual fatalities still total roughly 70,000, with overdoses remaining the leading cause of death among adults ages 18 to 44. Vaccine safety data are being suppressed. Pearl closes by describing blocked FDA and CDC research showing COVID and shingles vaccines to be safe and effective, warning that political censorship undermines trust and harms patients. Tune in for more fact-based analysis and practical perspective on the healthcare policies, technologies and trends shaping medicine today. * * * Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn. The post MTT #107: How politics is weakening America's public health defenses appeared first on Fixing Healthcare.

Healthcare is simultaneously propping up the US economy and facing one of its most uncertain moments in years.This month, Halle and Steve unpack the growing contradictions shaping digital health right now: healthcare jobs are driving nearly half of US job growth while provider bankruptcies surge, AI is flooding into healthcare faster than regulators can keep up, and Washington continues to send mixed signals on the future of healthcare policy and innovation.We cover:Why healthcare jobs are now carrying the US labor market and what Medicaid cuts could mean for the economyThe surprising comeback of wearables and how companies like Whoop, Oura, and Google are building massive subscription businessesCMS's new ACCESS model and the debate over whether AI-driven care can actually lower costs without sacrificing qualityThe lawsuit against Character.AI and what it reveals about the growing demand for AI mental health toolsWhy investors are pouring billions into AI drug discovery despite huge unanswered questions about clinical developmentMarty Makary's resignation from the FDA and what ongoing instability means for biotech, pharma, and healthcare innovation—Show notes:Forget Tech and Hollywood. California Is Powered by Healthcare Jobs. (WSJ)Oura Debuts Ring 5, Ahead of Potential IPO (WWD)Whoop Raises $575 Million at $10.1 Billion Valuation (Whoop)Fitbit Ditches the Screen With Its New $99 Whoop Rival (PC Mag)Why big digital health players are missing from Medicare's chronic care experiment (STAT)Character.AI Lawsuit (PA.gov) Marty Makary out as FDA chief (Axios)—

This week on We Want Them Infected, Jonathan Howard and Wendy Orent take a step back from the headlines to examine the academics, journalists, physicians, and commentators who helped legitimize and elevate the MAHA movement. They revisit articles, endorsements, and public statements that portrayed figures like Jay Bhattacharya, Marty Makary, and Vinay Prasad as reformers poised to restore trust in science and public health. With the benefit of hindsight, they explore how those predictions have aged, what has happened inside major health agencies, and why accountability matters when influential voices help shape public opinion.

On this week's episode, Chris Garabedian, Brian Skorney, Graig Suvannavejh, and special guest Ginkgo Bioworks CEO, Jason Kelly, kick off with a market update, highlighting a continued positive sentiment, citing Endpoints' recent Biopharma Sentiment Index survey results, which showed improvements in biopharma conditions. The co-hosts also note the continued IPO activity, including Kardigan's recent filing. The conversation shifts to China, with Jason suggesting that genetic engineering is a strategic technology extending beyond therapeutics, warning that the U.S. is offshoring critical innovation to China. This sparks a debate with others noting that global collaboration is embedded in drug development and questioning whether restricting partnerships would ultimately harm U.S. competitiveness. In deals, the group highlights Lilly's acquisition of three vaccine companies for up to $3.8 billion and Apogee's $1.3 billion strategic collaboration with Blackstone to advance their eczema drug. The conversation shifts to data, with GSK's Phase 3 data for chronic hepatitis B drug, and an overview of datasets at ASCO 2026, including Revolution Medicines Phase 3 trial results for pancreatic cancer, which are expected to be the headline of the conference. The episode concludes with an overview of Biohaven's R&D Day, BMS in multiple myeloma, Dyne's DMD, and updates on the FDA following the recent leadership changes. after the departure of Dr. Marty Makary. *This episode aired on May 29, 2026. 

Dr. Marty Makary out as FDA Commissioner—was he the victim of a BigPharma purge? Are “liquid biopsies” useful for predicting recurrences, as well as guiding therapy, for cancer? Nighttime smartphone by adolescents surges, eroding kids' sleep needs; Persistent itch may require an “all of the above” approach to break its vicious cycle—could topical vitamin B12 provide an answer? Study critiques research methods that fast-tracked new Alzheimer's drugs.

Jonathan Howard and Wendy Orent call this week their "Red Wedding": within days, FDA Commissioner Marty Makary resigned, Vinay Prasad was pushed out of CBER, Tracy Beth Hoeg was fired, and Senator Bill Cassidy lost his Louisiana primary. The hosts argue this is not a tragedy but a long-foretold collapse — a group of physicians who built careers as COVID-era contrarian podcasters discovering that running a regulatory agency is fundamentally different from posting about one. Howard works through the wreckage: Makary's reported approval of flavored nicotine products days before his ouster, the FDA's treatment of the rare disease community, the leaked memo claiming pediatric COVID vaccine deaths that career staff refused to sign off on, and the broader pattern of "regulatory whiplash" that drove the agency into dysfunction. The episode then turns to who is still standing — Jay Bhattacharya at NIH, Robert F. Kennedy Jr. at HHS — and what Kennedy is reportedly doing to vaccines from behind the scenes via Martin Kulldorff's review effort. Throughout, the hosts return to a single thesis: the skills that made Makary, Prasad, Hoeg, and Cassidy famous during COVID — opinion, tweeting, posturing — do not translate into running institutions, and the medical commentators who vouched for them (John Mandrola, Adam Cifu) have lost any remaining credibility. Key Topics Discussed Bill Cassidy's primary loss and the cost of the Kennedy confirmation vote Cassidy's earlier vote to convict Trump after January 6 followed by his decisive vote advancing RFK Jr. as HHS Secretary. Howard and Orent's view that Cassidy's promise to "keep Kennedy in line" was hollow from the start. What Cassidy's defeat signals about Trump's grip on the Republican base in Louisiana — and the hosts' read that his lame-duck status may give him cover to block the next round of HHS nominees. Marty Makary's resignation and the "worst FDA Commissioner in 25 years" framing The Stat News piece characterizing Makary's tenure, and the reporting that flavored nicotine was the precipitating issue with Trump's tobacco-industry donors. Howard's counterpoint: Makary reportedly approved a batch of electronic nicotine delivery systems (ENDS) on May 5, 2026 — the weekend before he resigned — undercutting the "principled stand" narrative. The pattern of selfie videos, public-facing performance, and what former FDA staff describe as hostile management of career scientists. Makary's pre-FDA record: the "medical error is the third leading cause of death" claim, Omicron as "nature's vaccine," "Omicold," herd immunity calls in May 2021, and the Nazi-bioweapon Lyme disease theory amplification. Vinay Prasad, regulatory whiplash, and the rare disease community How Prasad's stated preference for randomized controlled trials translated into rejection of rare disease therapies — and the disconnect between calling for RCTs on Twitter and the practical impossibility of running them for small patient populations. Right-to-try advocates, the libertarian wing of MAHA (Senator Ron Johnson), and why they turned on Prasad. Howard's point: Pfizer's halted COVID vaccine RCT in 50–65-year-olds is the case study — the trials Prasad demanded couldn't actually be enrolled. Tracy Beth Hoeg, the leaked pediatric deaths memo, and the Maryanne Demasi interview Hoeg's insistence she was fired, not resigned, and her interview with Brownstone Institute–adjacent journalist Maryanne Demasi. Her claim that the chaos at the FDA was "created by the media" rather than real. The memo alleging 10 pediatric deaths from the COVID vaccine that career FDA staff would not sign off on — and Howard's contrast with the J&J/thrombosis response, where nine deaths produced immediate, transparent action. Hoeg's role in the Denmark-style vaccine schedule rollback memo alongside Makary. The Makary–Prasad ZDoggMD clip on FDA "vindictiveness" — and the irony Audio pulled from a pre-appointment Prasad/Makary appearance describing the FDA as "erratic," "capricious," and politically pressured. Howard's read: every criticism they leveled at the Biden-era FDA describes their own tenure — political pressure from Trump, demoted career staff, inconsistent standards. The Peter Marks / Marion Gruber / Phil Krause booster episode reframed in light of what followed. John Mandrola, Adam Cifu, and the cost of vouching Mandrola's "Can We Give the New FDA's Leadership a Chance?" piece a year earlier — and the line about Prasad and Makary inducing companies to run proper RCTs, set against Pfizer's halted trial. Howard's account of an email exchange with Cifu following Cifu's visit to NYU — Howard's offer of a serious content-level conversation, and Cifu's decline. The broader "medical conservatives" project and what the hosts argue has happened to its credibility. Jay Bhattacharya, NIH, and the resignation letter from departing staff The letter from a senior NIH scientist on Bhattacharya's leadership — political termination of grants, deals institutions are making to recover funding, and Bhattacharya's silence. Howard and Orent's read on Bhattacharya's visible deterioration and his retreat into Great Barrington nostalgia. Kennedy's behind-the-scenes vaccine review and Martin Kulldorff The New York Times reporting (Christina Jewett and Sheryl Gay Stolberg) on Kennedy's vaccine inquiry being led by Kulldorff. Howard's pushback on the framing of Kulldorff as merely "a critic of restrictions and mandates" — and the 2020 record of his herd-immunity-through-infection advocacy, including his Stockholm "almost at herd immunity" claim in April 2020. The hosts' concern that the COVID amnesia project lets pandemic-era pro-infection figures re-enter regulatory power with their record sanitized. Casey Means, Surgeon General nomination withdrawal, and MAHA fracturing The withdrawn Surgeon General nomination and what it signals. The Robert Malone vs. Makary public falling-out over the unreleased pediatric deaths data. Why the MAHA coalition — held together by shared COVID grievance — is coming apart now that COVID has receded from headlines. Notable Moments On Cassidy: "He betrayed his oath as a physician, he betrayed the American people, and he's going down into the ignominious dust." — Wendy Orent On the Makary–Prasad–Hoeg trio: "The same skill sets that catapulted these guys to power — essentially being excellent podcasters — do not translate into leading a government agency of tens of thousands of employees that regulates 20 percent of the US economy." — Jonathan Howard On the legacy: "These guys are now cautionary tales for medical students. I would love to teach a course called 'Be the Opposite of Bill Cassidy, Marty Makary, Vinay Prasad, and Tracy Beth Hoeg.'" — Jonathan Howard On Bhattacharya: "His soul has been totally corrupted by the people who he teamed up with. You also see it in his face. He's not the same person that took the position." — Jonathan Howard References Mentioned in the Episode Stat News — "Why Marty Makary Was the Worst FDA Commissioner in 25 Years" Vinay Prasad's 2016 Stat News rebuttal of Makary's "medical error" claim David Gorski (Science-Based Medicine, 2016) — rebuttal of the medical-error-as-third-leading-cause-of-death claim Jonathan Howard, Science-Based Medicine — recent piece compiling Makary's COVID-era statements New York Times — Christina Jewett and Sheryl Gay Stolberg on Kennedy's vaccine inquiry Washington Post — "Ouster of RFK's Allies Tests MAHA-Trump Alliance" Ben Mazer, The Atlantic — on whether Makary and Prasad enacted lasting change Francis Lee — In COVID's Wake Alfred Crosby — America's Forgotten Pandemic Maryanne Demasi interview with Tracy Beth Hoeg MedPage Today — Makary and Prasad, "The Importance of Humility in Medicine" People Referenced Marty Makary — outgoing FDA Commissioner Vinay Prasad — former CBER Director Tracy Beth Hoeg — fired FDA official Senator Bill Cassidy (R-LA) — lost primary Robert F. Kennedy Jr. — HHS Secretary Jay Bhattacharya — NIH Director Martin Kulldorff — leading Kennedy's vaccine review Peter Marks — former CBER Director, Operation Warp Speed Bob Kadlec — Operation Warp Speed David Kessler — former FDA Commissioner (referenced) Marion Gruber and Phil Krause — former FDA vaccine reviewers John Mandrola and Adam Cifu — "medical conservative" commentators Robert Malone — anti-vaccine activist Casey Means — withdrawn Surgeon General nominee Senator Ron Johnson (R-WI) Representative Jake Auchincloss — opened FDA whistleblower line Art Caplan — bioethicist (retirement) Erica Schwartz — CDC Director nominee, unconfirmed  

The MAHA movement has hit some turbulence. Is it a few bumps or is it gonna crash? Casey Means for Surgeon General didn't happen. Marty Makary flamed out at FDA. On this episode, Helena and Theodore discuss what it means for the movement, plus what the work requirements for SNAP are doing around the country. Bonus: Theodore brags about his James Beard Media Award nominations.

Marty Makary wasn't the only official on the outs at FDA last week in another tumultuous turn of events for the regulatory agency. On the latest BioCentury This Week podcast, BioCentury Washington Editor Steve Usdin discusses who's in, who's out and what's next at FDA — and why the changes may mean more conservative decision-making at the agency in the near term.BioCentury's analysts also discuss the new obesity targets that came to light at last week's annual meeting of the European Congress on Obesity, the market for biotech IPOs, and the emergence of degrader-antibody conjugates. DACs pair the tissue-targeting logic of antibody-drug conjugates (ADCs) with the catalytic activity of protein degraders. 3C Therapeutics is the latest entrant to the field, pitching its TriCore platform as a modular backbone for DAC generation. This episode of the BioCentury podcast is brought to you by Jeito Capital.View full story: https://www.biocentury.com/article/659510#FDA #ObesityDrugDevelopment #BiotechIPO #DACs #Biopharma00:01 - Sponsor Message: Jeito Capital 02:53 - FDA Leadership Shakeup10:35 - Obesity Target Hunt16:07 - Biotech IPOs20:02 - Degrader-antibody Conjugates28:42 - Serif: Non-viral DNATo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The industry is currently navigating a pivotal era marked by a blend of scientific innovation, regulatory shifts, and intriguing clinical trial results. A key regulatory upheaval unfolds as the FDA faces leadership changes. The recent departures of key figures from both the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER) underscore a period of uncertainty. With former commissioner Marty Makary stepping down, concerns arise about how these changes might affect drug approvals and regulatory guidance at such a crucial time in the industry. Turning to clinical trials, Regeneron has experienced a setback as its lag-3 inhibitor failed to surpass Merck's Keytruda in phase 3 melanoma studies. This marks Regeneron's second significant late-stage failure within a year, prompting analysts to reassess its strategic direction in oncology. In parallel, Regeneron has inked a $2.3 billion agreement with Parabilis Medicines to develop an advanced antibody-drug conjugate (ADC)-like therapy. The goal is to enhance targeting capabilities by improving binding to complex target sites, which could revolutionize ADC technology. Similarly, BioMarin's substantial investment in Inozyme's enzyme replacement therapy faced hurdles after falling short on one of two primary endpoints in a phase 3 trial for a rare genetic disorder. Such outcomes highlight the inherent risks and high stakes involved in late-stage drug development. Yet, innovation continues to drive progress. Vincentage Pharma's oral GLP-1 agonist has demonstrated a promising mean weight loss of 12.4% over a year, positioning it as a competitor to Eli Lilly's Orforglipron in the burgeoning Chinese market. This reflects the global pursuit to harness GLP-1 receptor agonists in tackling metabolic disorders and obesity. Ipsen has made strides with its long-acting neurotoxin for aesthetic applications, advancing into phase 3 trials following encouraging phase 2 results that showed significant improvements in frown lines lasting up to 24 weeks post-treatment. This progress suggests robust competition against established players like Botox. Meanwhile, Merck and Kelun-Biotech have successfully completed a phase 3 trial with their trop2-directed ADC sacituzumab tirumotecan (SAC-TMT) for endometrial cancer, achieving primary endpoints and paving the way for further regulatory submissions. Such advancements emphasize ADC technology's growing importance in oncology therapeutics. Broad industry trends reflect strategic investments, exemplified by Boston Scientific's $1.5 billion investment in Mirus and an option to acquire its transcatheter aortic valve replacement system—highlighting continued interest in high-growth medtech sectors. In another notable development, Daiichi Sankyo and AstraZeneca have reached a milestone with their ADC Enhertu, securing dual FDA approvals for early breast cancer treatment. These approvals underscore Enhertu's potential to expand treatment options for patients at an early disease stage, potentially altering standard treatment protocols. On the regulatory front, AstraZeneca has secured FDA approval for baxdrostat—an aldosterone synthase inhibitor developed through its acquisition of CinCor Pharma—demonstrating strategic investment in innovative cardiovascular therapies aligned with ambitious revenue goals. However, challenges persist as demonstrated by Amgen's Tavneos being linked to fatalities across Japan and the U.S., raising significant concerns about data integrity and pharmacovigilance. In contrast, Revolution Medicines' RAS inhibitor doubled survival rates in phase 3 pancreatic cancer trials. This breakthrough positions Revolution as an emerging leader in oncology therapeutics amidst fierce competition from companies aiming to improve drug tolerability and extend survival benefits. These narratives paint a picture of an industry poised for transformation—balancing scientific breakthroughs against regulatory challenges and financial pressures. As therapeutic modalities evolve—from oral biologics to advanced ADCs—the sector is set on course for substantial impacts on patient care and drug development pipelines. In summary, the pharmaceutical and biotech industries' focus on advancing therapeutic options through scientific innovation while navigating complex regulatory landscapes underscores an ongoing commitment to addressing unmet medical needs through new drug classes and targeted therapies. These efforts highlight trends toward personalized medicine and precision oncology that are likely to shape future trajectories in these dynamic fields.Support the show

As Donald Trump leaves Beijing after meeting Xi Jinping, how much did this diplomacy accomplish? Plus, does Dr. Marty Makary's resignation at the FDA signal an agency turn? And the High Court halts an appellate ruling against mail-order mifepristone, the abortion pill, with no liberal dissents about the "shadow docket." Learn more about your ad choices. Visit megaphone.fm/adchoices

Jordan Sather and Nate Prince break down a packed week in health news. Marty Makary is out as FDA chief under circumstances that remain murky, with Dr. Malone having previously claimed Makary was blocking COVID vaccine death data from going public. Interim replacement Kyle Diamantis is a food lawyer who represented CBD companies and quit a Planned Parenthood case over moral objections. Kennedy moves fast, announcing the FDA will now continuously review food chemicals already on the market, starting with BHT and ADA. A CIA whistleblower from Tulsi Gabbard's ODNI task force testifies before Congress about the intelligence community's COVID cover up, and Rand Paul drops a bombshell: Fauci allegedly bribed a scientist with a $9 million grant to flip his position on lab leak origins. Dr. Oz reveals 800 fraudulent Medicare providers were quietly removed and none of them called to dispute it. And farmed fish? Sedated. Vaccinated. By conveyor belt.

The Supreme Court says abortion pills can still be mailed… FOR NOW! Which means Lizz and Moji have spent the last several days stress sweating through every twist, loophole, and terrifying little breadcrumb in this mifepristone decision. We break down what the ruling actually means, how Clarence Thomas and Sam Alito continue their quest to become the most divorced-from-reality men alive, and why anti-abortion extremists are still doing everything they can to drag abortion access back to the Stone Age using junk science, legal chaos, and the world's crustiest ideology.   AND because the universe refuses to let us rest for even one second, FDA Commissioner Marty Makary is OUT. Depending on which weird little corner of the internet you ask, it's either because he wouldn't let kids rip bubblegum-flavored vape clouds in peace OR because anti-abortion lawmakers were furious he wasn't moving fast enough to ban abortion pills nationwide. Honestly? In this timeline, both sound possible.   GUEST ROLL CALL: The absolutely brilliant Solomon Georgio joins the Buzzkills this week, and trust us, we needed him. The comedian, TV writer, and professional destroyer of bad vibes talks with Lizz and Moji about dealing with hecklers, navigating MAGA comedy crowds, dating disasters, surviving America as a 6'4” Black queer immigrant, and somehow still remaining one of the funniest people alive while the country freefalls directly into the sun.   The news is unhinged, the lawmakers are embarrassing, and the vibes are medically concerning, but knowledge is power, rage is fuel, and we gotchu.   URGENT ACTION: Share Your Medication Abortion Story Now! Telling your story can help protect mifepristone and ensure others have the same opportunity you did to choose their own path. This is a moment that needs all of us to share our stories, amplify them in our communities, and turn them into real, lasting change. Share your experience with medication abortion at MifeStories.com   HOSTS: Lizz Winstead IG: @LizzWinstead Bluesky: @LizzWinstead.bsky.social Moji Alawode-El IG: @Mojilocks Bluesky: @Mojilocks.bsky.social   SPECIAL GUEST: Solomon Georgio IG: @SolomonGeorgio Bluesky: @SolomonGeorgio.bsky.social   GUEST LINKS: Solomon's Website   NEWS DUMP: The Supreme Court Keeps Abortion Pill Mifepristone Available by Telehealth Epa's Lee Zeldin Makes Critical Mistake Jeni's Ice Cream in Ohio Florida's “Free Kill Law” Explained ‘Americans Are Under-Babied': Dr Oz Issues Stark Warning Over Us Fertility ‘Crisis' WATCH: Mother's Day Roundtable: moms.gov Launch   EPISODE LINKS: MifeStories.com Abortion Finder Catholics for Choice ADOPT-A-CLINIC: NYC For Abortion Rights 6 DEGREES: FIFA World Cup Cultural Passport  Look At the FIFA Peace Prize LOL SUBSTACK: Abortion Access Front Operation Save Abortion Expose Fake Clinics Expose Fake Clinics Action Hour on May 27! BUY AAF MERCH! EMAIL your abobo questions to The Feminist Buzzkills AAF's Abortion-Themed Rage Playlist   FOLLOW US: Listen to us ~ FBK Podcast Instagram ~ @AbortionFront Bluesky ~ @AbortionFront TikTok ~ @AbortionFront Facebook ~ @AbortionFront YouTube ~ @AbortionAccessFront   TALK TO THE CHARLEY BOT FOR ABOBO OPTIONS & RESOURCES HERE! PATREON HERE! Support our work, get exclusive merch and more!  DONATE TO AAF HERE! ACTIVIST CALENDAR HERE! VOLUNTEER WITH US HERE! ADOPT-A-CLINIC HERE! GET ABOBO PILLS FROM PLAN C PILLS HERE!   When BS is poppin', we pop off!   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On this week's episode, Sam Fazeli, Josh Schimmer, Eric Schmidt, and Tess Cameron kickoff with deals, highlighting the up to $15.2B Hengrui–BMS partnership and the broader trend of outsourcing early-stage drug development to China. The discussion continues with the co-hosts noting China's edge in speed, quality, and cost-efficiency, while underscoring that the strength of U.S. capital markets remains a key advantage. This week also saw a significant raise, with Isomorphic Labs announcing a $2.1B Series B. In regulatory news, the group described the departure of FDA Commissioner Dr. Marty Makary as creating fresh uncertainty around FDA leadership and direction as they speculated on his exit and who will replace him. On the data front, Regenxbio met the primary endpoint inits Phase 3 trial for Duchenne, though the hosts flagged potential investor skepticism around the side effects, limited data, and FDA uncertainty. Next, they discuss that Biogen and Ionis are advancing their Alzheimer's tau program despite mixed results. The co-hosts also mention Inhibrx's Phase 2 data in head and neck squamous cell carcinoma, as well as Moderna's Hantavirus vaccine research following the recent cruise ship outbreak. The episode concludes with a look ahead to upcoming conferences, including ASCO, ADA, and ATS. *This episode aired on May 15, 2026.

This week, Emily Bazelon, John Dickerson, and David Plotz discuss the geopolitical dynamics and possible outcomes of the Trump-Xi summit with former New York Times Beijing Bureau Chief and host of Face-Off: the US vs. China, Jane Perlez, whether or not the United States has essentially lost the war it started in Iran, and how badly the latest round of gerrymandering will hurt the Democrats and America as a whole in the upcoming midterms and beyond. For this week's Slate Plus bonus episode, Emily, John, and David discuss who actually benefits from this week's resignation of FDA chief Marty Makary amid overlapping pressure campaigns from the tobacco industry and anti-abortion groups. In the latest Gabfest Reads, Emily Bazelon talks with journalist Mark Oppenheimer about his new book, Judy Blume: A Life. Oppenheimer, who spent years with Blume's papers at Yale and conducted extensive interviews with the author herself, traces how a restless housewife in New Jersey became one of the most beloved—and most banned—writers in American history. Email your chatters, questions, and comments to gabfest@slate.com. (Messages may be referenced by name unless the writer stipulates otherwise.) Podcast production by Nina Porzucki Research by Emily DittoYou can find the full Political Gabfest show pages here. Want more Political Gabfest? Join Slate Plus to unlock weekly bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Political Gabfest show page on Apple Podcasts and Spotify. Or visit slate.com/gabfestplus to get access wherever you listen. Find out more about David Plotz's monthly tours of Ft. DeRussy, the secret Civil War fort hidden in Rock Creek Park. Follow@SlateGabfest on X / https://twitter.com/SlateGabfestSlate Political Gabfest on Facebook / https://www.facebook.com/Gabfest/Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required. Hosted on Acast. See acast.com/privacy for more information.

This week, Emily Bazelon, John Dickerson, and David Plotz discuss the geopolitical dynamics and possible outcomes of the Trump-Xi summit with former New York Times Beijing Bureau Chief and host of Face-Off: the US vs. China, Jane Perlez, whether or not the United States has essentially lost the war it started in Iran, and how badly the latest round of gerrymandering will hurt the Democrats and America as a whole in the upcoming midterms and beyond. For this week's Slate Plus bonus episode, Emily, John, and David discuss who actually benefits from this week's resignation of FDA chief Marty Makary amid overlapping pressure campaigns from the tobacco industry and anti-abortion groups. In the latest Gabfest Reads, Emily Bazelon talks with journalist Mark Oppenheimer about his new book, Judy Blume: A Life. Oppenheimer, who spent years with Blume's papers at Yale and conducted extensive interviews with the author herself, traces how a restless housewife in New Jersey became one of the most beloved—and most banned—writers in American history. Email your chatters, questions, and comments to gabfest@slate.com. (Messages may be referenced by name unless the writer stipulates otherwise.) Podcast production by Nina Porzucki Research by Emily DittoYou can find the full Political Gabfest show pages here. Want more Political Gabfest? Join Slate Plus to unlock weekly bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Political Gabfest show page on Apple Podcasts and Spotify. Or visit slate.com/gabfestplus to get access wherever you listen. Find out more about David Plotz's monthly tours of Ft. DeRussy, the secret Civil War fort hidden in Rock Creek Park. Follow@SlateGabfest on X / https://twitter.com/SlateGabfestSlate Political Gabfest on Facebook / https://www.facebook.com/Gabfest/ Hosted on Acast. See acast.com/privacy for more information.

-- On the Show: -- Rising credit card, student loan, auto loan, and mortgage delinquencies show millions of Americans falling behind in Trump's economy -- Marty Makary resigns as FDA commissioner amid pressure from Trump allies pushing restrictions on abortion medication and antidepressants -- Donald Trump praises Xi Jinping repeatedly during a public appearance while making strange comments about Chinese food -- Xi Jinping warns tensions over Taiwan could lead to direct conflict between China and the US as Trump sends inconsistent signals -- Democratic lawmakers publicly question Donald Trump's mental fitness after late night Truth Social posts, rambling speeches, and other evidence -- JD Vance attempts to soften Trump's comments about ignoring Americans' financial struggles while awkwardly distancing himself -- Sebastian Gorka claims Trump keeps an “if I die” letter for JD Vance in the Resolute Desk as allies increasingly talk about assassination plots -- Barack Obama defends the Iran nuclear deal by pointing out that it reduced Iran's uranium stockpile without resulting in a war -- On the Bonus Show: Trump explores 250 pardons to celebrate America's 250th, fuel in Cuba has run out due to the US blockade, Florida's history course whitewashes the founding fathers on slavery, and much more...

This week, Emily Bazelon, John Dickerson, and David Plotz discuss the geopolitical dynamics and possible outcomes of the Trump-Xi summit with former New York Times Beijing Bureau Chief and host of Face-Off: the US vs. China, Jane Perlez, whether or not the United States has essentially lost the war it started in Iran, and how badly the latest round of gerrymandering will hurt the Democrats and America as a whole in the upcoming midterms and beyond. For this week's Slate Plus bonus episode, Emily, John, and David discuss who actually benefits from this week's resignation of FDA chief Marty Makary amid overlapping pressure campaigns from the tobacco industry and anti-abortion groups. In the latest Gabfest Reads, Emily Bazelon talks with journalist Mark Oppenheimer about his new book, Judy Blume: A Life. Oppenheimer, who spent years with Blume's papers at Yale and conducted extensive interviews with the author herself, traces how a restless housewife in New Jersey became one of the most beloved—and most banned—writers in American history. Email your chatters, questions, and comments to gabfest@slate.com. (Messages may be referenced by name unless the writer stipulates otherwise.) Podcast production by Nina Porzucki Research by Emily DittoYou can find the full Political Gabfest show pages here. Want more Political Gabfest? Join Slate Plus to unlock weekly bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Political Gabfest show page on Apple Podcasts and Spotify. Or visit slate.com/gabfestplus to get access wherever you listen. Find out more about David Plotz's monthly tours of Ft. DeRussy, the secret Civil War fort hidden in Rock Creek Park. Follow@SlateGabfest on X / https://twitter.com/SlateGabfestSlate Political Gabfest on Facebook / https://www.facebook.com/Gabfest/ Hosted on Acast. See acast.com/privacy for more information.

In one of the most widely expected departures in recent memory, Marty Makary stepped down as head of the FDA this week. Meanwhile, the Supreme Court is considering blocking telehealth prescriptions for the abortion pill mifepristone. Lauren Weber of The Washington Post, Alice Miranda Ollstein of Politico, and Rachel Cohrs Zhang of Bloomberg News join KFF Health News' Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Sen. Tammy Baldwin (D-Wis.) about health issues before Congress. Plus, for “extra credit” the panelists suggest health policy stories they read this week that they think you should read, too: Julie Rovner: ProPublica's “A Unique Oregon Law Allows It To Block Healthcare Deals. In Five Years, the State Hasn't Done So Once,” by Rob Davis. Rachel Cohrs Zhang: The Wall Street Journal's “Inside Marty Makary's Downfall at the FDA,” by Liz Essley Whyte and Josh Dawsey.  Alice Miranda Ollstein: Politico's “Lawmakers' Prescription Data at Risk After Data Breach,” by Katherine Tully-McManus.  Lauren Weber: Stat's “Alcohol Is Wreaking Havoc on U.S. Public Health. American Society Looks the Other Way,” by Lev Facher and Isabella Cueto. 

Kevin Sabet debates Matt Johnson on the Illusion of Consensus podcast with host Rav Arora, covering Trump's psychedelic executive order, ibogaine, FDA approval, Right to Try, drug scheduling, and the future of psychedelic research. Sabet, a former White House drug policy advisor across the Clinton, Bush, and Obama administrations, argues for caution around psychedelics, marijuana policy, commercial incentives, and overstated medical claims. Johnson, a leading Johns Hopkins psychedelic researcher, responds on psilocybin studies, addiction treatment, depression, safety protocols, REMS, and why accelerated research may still follow the evidence. The discussion also covers Joe Rogan, RFK Jr., Marty Makary, Jay Bhattacharya, ketamine clinics, MDMA, MAPS, cannabis rescheduling, veteran suicide, and the risks of turning experimental drugs into public policy too quickly. Subscribe to Rav's Substack to get episodes straight to your inbox: https://www.illusionconsensus.com Chapters: 0:00 - Intro 2:05 - Sabet's Objection to Psychedelics 10:00 - Matt's Disagreement with Sabet 13:15 - Psychedelic Research Quality 21:10 - Kevin's Rebuttal 24:00 - Was Joe Rogan Wrong On Ibogaine's Efficacy 32:50 - Ibogaine Safety Concerns 40:50 - Could The Executive Order Go Too Far 46:10 - Rescheduling and FDA Approval

In this special episode of Snubie's Pouchcast, we sit down Laura Leigh Oyler (VP Reg. Affairs Nicokick.com/Northerner.com), and Alex Clark (former CEO of CASAA)! We discuss FDA news, the departure of Marty Makary (though when we recorded this it was just a rumor), and take YOUR questions! For all the breaking snus news, newest reviews, and extensive information - http://www.Snubie.comSnubie Podcast - http://www.PouchCast.comSocial Media:Facebook - http://www.Facebook.com/SnubieInstagram - http://www.Instagram.com/SnubieDotComTwitter/X - http://www.X.com/SnubieDotComReddit - http://www.reddit.com/r/SnubieDotCom

President Trump is in Beijing today meeting Chinese President Xi Jinping, with American manufacturers hoping for tariff relief even as the war in Iran looms over the high-stakes summit.The Pentagon told Congress they estimate the war in Iran has cost $29 billion dollars so far. Defense Secretary Pete Hegseth asked for $1.5 trillion dollars for next year's Pentagon budget.FDA Commissioner Dr. Marty Makary has resigned after thirteen months on the job, with the final straw being White House pressure to approve flavored vapes, something he refused to do.Want more analysis of the most important news of the day, plus a little fun? Subscribe to the Up First newsletter.Today's episode of Up First was edited by Miguel Macias, Jason Breslow, Kris Husted, Mohamad El-Bardicy and John Stolnis.It was produced by Ziad Buchh and Nia Dumas Our director is Christopher Thomas.We get engineering support from Neisha Heinis. And our Supervising Producer is Michael Lipkin.(0:00) Introduction(01:57) Trump In China(05:40) Hegseth Requests Wartime Budget(09:26) FDA Commissioner ResignsSee pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy

President Donald Trump is arriving in Beijing today on a long-awaited trip – one that got delayed even further by Trump's war in Iran. It's Trump's second trip to China and his first in nearly a decade. It's also a trip where both sides see big opportunities (mostly to make money). But, the global balance of power has shifted – arguably, in China's favor. Trump is in the midst of an unpopular war with no clear exit plan and he's looking to make deals, not problems. Meanwhile, China has become an economic and military powerhouse more than able to stand up to the US and Trump's trade wars. So to talk more about Trump's trip to China and what's at stake, we spoke to Phelim Kine. He is the DC based China correspondent at POLITICO.And in headlines, Secretary of War/little boy Pete Hegseth returns to the Hill, Food and Drug Administration head Marty Makary steps down, and the What A Day newsletter investigates a new video game that parodies Trump's second term in office.Show Notes: Check out Phelim's work – politico.com/staff/phelim-kine Call Congress – 202-224-3121 Subscribe to the What A Day Newsletter – https://tinyurl.com/y4y2e9jy What A Day – YouTube – https://www.youtube.com/@whatadaypodcast Follow us on Instagram – https://www.instagram.com/crookedmedia/ For a transcript of this episode, please visit crooked.com/whataday

This is The Briefing, a daily analysis of news and events from a Christian worldview.On today's edition of The Briefing, Dr. Mohler discusses what to watch for as President Trump goes to Beijing, Chinese spies in U.S. political offices, the theater of international diplomacy, and the end of Dr. Marty Makary's tenure as FDA Commissioner.Part I (00:13 – 12:57)Statecraft on the World Stage: What to Watch For as President Trump Goes to BeijingPart II (12:57 – 18:19)Chinese Spies in U.S. Political Offices: China is Seeking to Subvert the American System, Which Includes Infiltrating America With Its Own AgentsCalifornia Mayor Will Plead Guilty to Working as Agent of China by The New York Times (Pooja Salhotra)He Offered a Lawmaker's Aide Quick Cash. Was He Spying for China? by The New York Times (Dustin Volz)Part III (18:19 – 22:27)Diplomatic Security and President Trump's Visit to China: Honor, Dignity, and the Deeply Serious (and Sometimes Absurd) Theater of International DiplomacyHow to Avoid Fistfights and Poisonings at a World Leaders Summit by The Wall Street Journal (Lingling Wei)Part IV (22:27 – 25:43)Dr. Marty Makary Spends His Ninth Political Life: Dr. Makary is Out as FDA Commissioner – This Could Be a Big Win for the Pro-Life MovementHawley Statement on Resignation of FDA Commissioner Makary by U.S. Senator for Missouri (Sen. Joshua Hawley)Sign up to receive The Briefing in your inbox every weekday morning.Follow Dr. Mohler:X | Instagram | Facebook | YouTubeFor more information on The Southern Baptist Theological Seminary, go to sbts.edu.For more information on Boyce College, just go to BoyceCollege.com.To write Dr. Mohler or submit a question for The Mailbox, go here.

President Donald Trump just went full alpha on a reporter who tried to gotcha him over the new White House ballroom project.During a press event, reporter Akayla Gardner questioned the rising costs of the massive new ballroom. Trump fired back without hesitation: “I doubled the size of it, you dumb person. You are not a smart person.” We also cover: Update on Iran.  Trump on inflation.  Pete Hegseth testifies on Ukraine war.  FDA secretary resignation. Kirk Cameron joins.  This is classic Trump — strong, unapologetic, and always putting America first. While Democrats and the fake news media cry about “tone”, President Trump continues delivering results and standing up to the swamp. If you love seeing Trump fight back against the biased press, smash that LIKE button

Howie Kurtz on the resignation of FDA Commissioner Marty Makary over flavored e-cigarettes, the Justice Department's aggressive crackdown on leakers, and President Trump's controversial Truth Social posts calling for the arrest of former President Barack Obama. Learn more about your ad choices. Visit podcastchoices.com/adchoices

It's Wednesday, May 13th, A.D. 2026. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Jonathan Clark and Timothy Reed Mexican cartel violence forces families to flee The Mexican state of Guerrero is seeing major drug cartel violence from the group Los Ardillos, forcing families and local citizens to flee. Mexican national forces are almost nowhere to be seen in the region, and according to Marina Velascho, representative of the People's Indigenous Council of Guerrero, “These have been days of terror. They've been bombing communities with drones, and how can one defend themselves from a drone, with bombs falling from the sky.”  Elderly Protestant missionary kidnapped by Mexican drug thugs The recent violence in the Mexican state of Guerrero is also affecting Christians. Benito Guevara Arcos, a 79-year-old Protestant missionary, disappeared from the area in recent weeks. An organized criminal group had kidnapped the missionary after taking exception to his preaching. Sadly, disappearances in Mexico have surged over 200 percent in the last decade. Anna Stangl with Christian Solidarity Worldwide said, “We urge the Mexican government, at all levels, to increase efforts to arrest the influence of organized criminal groups in the country, recognizing the specific threat that these groups pose to religious leaders.” In John 10:10, Jesus said, “The thief comes to steal, and to kill, and to destroy. I have come that they may have life, and that they may have it more abundantly.”  Trump lumps in radical transgenders with Islamic terrorists In the United States, the Trump administration is cracking down on transgender ideology and the radical left. Transgenderism is identified as a major threat in the United States' newly released Counterterrorism Strategy for 2026. Far left groups have been placed on a watch list. The document stated, “In addition to cartels and Islamist terror groups, our national count terrorism activities will also prioritize the rapid identification and neutralization of violent secular political groups whose ideology is anti-American, radically pro-transgender, and anarchist.”  Marty Makary, who oversaw generic Abortion Kill Pill, out at FDA Dr. Marty Makary is out as commissioner of the Food and Drug Administration, reports The Western Journal. He announced his resignation Tuesday, May 12th, amid policy differences with President Donald Trump and prominent Republican senators, reports Politico. Kyle Diamantas, who previously worked as the top food official at the agency, will lead the FDA in an acting capacity. Makary has received backlash for his handling of the Abortion Kill Pill and vaccines. Marjorie Dannenfelser, the president of Susan B. Anthony Pro-Life America, had called for Makary to be ousted. She wrote, “This is a five-alarm crisis for the pro-life movement and for the GOP. The GOP cannot win without its base and simply will not get the enthusiasm that drives turnout without leadership from the top.” Republican Senator Josh Hawley of Missouri tweeted, “This is welcome news. Dr. Makary was uniquely destructive to the pro-life movement. He attempted to place pro-abortion lawyers in key positions. He slow-walked a vitally necessary review of the abortion drug mifepristone. He used his discretion to approve a new abortion drug when the data shows it sends 1 in 10 women to the emergency room. He froze out prolife leaders and repeatedly stonewalled Congress. His resignation is an opportunity for the FDA to reset.” Southwest Airlines paid $1 million to fired pro-life stewardess Life News reports that Southwest Airlines paid nearly one million dollars to a pro-life stewardess last week. Charlene Carter had worked as a flight attendant for over 20 years. In 2017, she sent a message to the Transport Workers Union, protesting its support for abortion. She sued after the union and Southwest Airlines fired her for her pro-life speech. The recent settlement ends a nine-year legal battle. The National Right to Work Foundation represented Carter in the lawsuit. Listen to comments from Mark Mix, the president of National Right to Work Foundation. MIX: “What ended up as a long battle ended up well for Charlene Carter, and hopefully spreads the word to other employees that want to speak up on issues related to their beliefs and their ideas. The union can't thwart that. And that's what this case is all about.” Prices continue to skyrocket The prices of goods and services in the U.S. continued to rise last month.  The Labor Department reported inflation was up 3.8 percent in April compared to a year earlier. It's the biggest annual increase since 2023. Meanwhile, wages only grew 3.6 percent from April last year. This means inflation outpaced wage growth for the first time since 2023. Since the Iran war, Americans are seeing higher prices particularly for gasoline, electricity, and food.  50% of 18 to 24-year-old Christians are reading Bible weekly And finally, a new report found young Christians are engaging with the Bible more than older generations. The Patmos Youth Report surveyed nearly 30,000 young respondents around the world.  The report found half of Christians aged 18-24 read the Bible on a weekly basis. That level of Bible engagement is higher than older generations. Bible engagement was particularly high in the regions of Latin America and Sub-Saharan Africa.   Psalm 144:12 and 15 says, “May our sons in their youth be like plants full grown, our daughters like corner pillars cut for the structure of a palace . . . Blessed are the people to whom such blessings fall! Blessed are the people whose God is the LORD!” Close And that's The Worldview on this Wednesday, May 13th, in the year of our Lord 2026. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  Plus, you can get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

Dr. Marty Makary is out as FDA commissioner. Sanford Health plans to merge with Minnesota-based North Memorial Health. And healthcare added the most jobs in April. Coming up on today's episode of The Gist Healthcare Podcast. Hosted on Acast. See acast.com/privacy for more information.

The Gary & Shannon Show Hour 3 (05.13) – the Murdaugh conviction gets overturned, President Trump meets with President Xi amid Iran tensions, and #Parenting spirals into stories about parents trying to get teachers fired and families outraged over $100 sports fees.• #WhatsHappening → President Trump meets with Xi Jinping as tensions with Iran continue complicating trade negotiations• South Carolina overturns Alex Murdaugh’s murder conviction and orders a new trial• Plus: California’s governor race continues consolidating around Xavier Becerra while Steve Hilton holds strong Republican support• Also: the drug counselor tied to Matthew Perry’s ketamine overdose faces sentencing, and Conan O'Brien is asked back to host the Oscars again• #SWAMPWATCH → China’s role as Iran’s top oil buyer takes center stage during Trump’s overseas meetings• Gary & Shannon also break down a bizarre report on President Trump’s Truth Social posting habits, FDA shakeups involving Marty Makary, and FBI Director Kash Patel trading barbs with Congress during a very unserious hearing• Then it’s #Parenting with Justin Worsham → including stories from teachers sharing the wild reasons parents tried getting them fired• The hour wraps with a debate over growing outrage surrounding $100 fees just to let kids play high school sportsSee omnystudio.com/listener for privacy information.

U.S. President Donald Trump lands in Beijing today hoping that Chinese President Xi Jinping will help him end his unpopular Iran war. Reuters exclusively reports that Saudi Arabia launched unpublicized strikes on Iran in March – the first time the kingdom is known to have directly carried out military action on Iranian soil. U.S. consumer prices continued to rise last month delivering the largest annual inflation increase in nearly three years. Marty Makary resigns as FDA commissioner. And the Cannes Film Festival kicks off.  Listen to the Morning Bid podcast ⁠⁠here⁠⁠. Sign up for the Reuters Econ World newsletter ⁠⁠here⁠⁠. Listen to the Reuters Econ World podcast ⁠⁠here⁠⁠. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices

AlabamaGovernor Ivey says state will hold special primary elections on August 11thTwo groups file motion in federal court to stop use of 2023 district mapDemocrat Juandalyn Givan calls Justice Clarence Thomas an "Uncle Tom"AL House Speaker calls out unprofessional behavior of Dem Lawmakers8 GOP state senate candidates call for investigation into an AL PAC and its finance recordsNationalDr. Marty Makary tenders resignation as FDA director to President TrumpWhite House places official on leave after undercover video release KY Senator brings CIA whistleblower to senate committee re: Covid originsTN House Speaker strips all Dem lawmakers of committee assignments following melee on House floor earlier this weekGeorgia state senate committee issues subpoena to Stacy Abrams over campaign finance questions

Why Are Conservatives SO Triggered By Pride Flags? | Trump, FIFA & The Culture War Explained Pride Month is here, and once again the culture war is raging over one thing: the rainbow flag. Iran wants FIFA to ban Pride flags, Trump allies want them removed from public spaces, and cities across America are fighting over Pride displays and even rainbow sidewalks. But why does a symbol of inclusion make so many people so angry? Today on The Karel Show, Karel breaks down the real reason Pride flags trigger certain conservatives, the politics behind the outrage, and why LGBTQ visibility still scares so many in 2026. Plus: * Trump prepares for a very different showdown with China's leader Xi Jinping — and this isn't Putin. * FDA turmoil erupts as Marty Makary reportedly clashes with Trump-world over flavored vape policies. * Why vaping is far more dangerous than people admit. * And on The Boys, Sister Sage proves a painful truth liberals often forget: intelligence without strategy can still lose. The culture wars aren't slowing down — they're escalating. Support independent media and The Karel Show at: Patreon Watch and subscribe: YouTube Channel Streaming everywhere including Apple Podcasts, Spotify, iHeartRadio and Spreaker. #PrideFlag, #PrideMonth, #LGBTQ, #Trump, #FIFA, #RainbowFlag, #CultureWar, #Politics, #GayRights, #Pride2026, #Conservative, #Liberal, #TheBoys, #SisterSage, #XiJinping, #China, #FDA, #Vaping, #News, #CurrentEvents, #PoliticalCommentary, #LGBTQRights, #Equality, #Podcast, #YouTubePolitics, #DonaldTrump, #Pride, #CultureWars, #IndependentMedia, #TheKarelShow https://youtube.com/live/Zy3yAlj2gEY

Trump heads to China for talks with Xi, Israel establishes a live streamed Oct. 7 tribunal, Trump says the Iran ceasefire is on "massive life support," FDA Chief Dr. Marty Makary resigns, four British minister quit amid calls for Starmer's resignation, Zelenskyy's former press secretary accuses him of corruption and drug abuse on the Tucker Carlson Show, former Arcadia, California, mayor Eileen Wang pleads guilty to acting as an agent for China, U.S. inflation hits 3.8%, the hantavirus-hit MV Hondius departs Tenerife after the last passengers disembarks, and Polycystic Ovary Syndrome is officially renamed following a 14-year study. Sources: Verity.News

Pete Hegseth sounds the alarm over a Cuban threat to national security, MAHA favorite Marty Makary resigns from the FDA, and President Trump moves beyond Canada–and teases making Venezuela the 51st state. Get the facts first with Evening Wire. - - - Ep. 2783 - - - Wake up with new Morning Wire merch: https://bit.ly/4lIubt3  - - - Today's Sponsor: ZipRecruiter - Post jobs FOR FREE at https://ZipRecruiter.com/WIRE - - - Privacy Policy: ⁠https://www.dailywire.com/privacy⁠ morning wire,morning wire podcast,the morning wire podcast,Georgia Howe,John Bickley,daily wire podcast,podcast,news podcast Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Marty Makary has resigned as commissioner of the Food and Drug Administration. Makary faced criticism over the FDA's rejections of rare-disease drugs, the agency's handling of abortion pills and high-profile departures of key FDA staff. But WSJ's Liz Essley Whyte reports that it was a battle over flavored vapes that sealed Makary's fate. Jessica Mendoza hosts. Further Listening: - The Flu Shot Drama at the FDA - The FDA Boss on the Agency's MAHA Makeover - How Puff Bar Became the Most Popular Vape for KidsSign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

In our news wrap Tuesday, FDA head Marty Makary is resigning after an uneven tenure at the agency, UK Prime Minister Keir Starmer is refusing to resign despite growing pressure from within his own party, and FBI Director Kash Patel pushed back against accusations that he drinks to excess on the job and is at times unreachable by his staff. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Marty Makary's hold on the top job at FDA is slipping, with White House leaks about President Donald Trump's displeasure with the FDA commissioner shifting the question from whether he will be fired to when. On the latest BioCentury This Week podcast, Washington Editor Steve Usdin discusses the pressures on Makary, how long he will hold onto his post, and the leading candidates to succeed him.BioCentury's analysts then discuss solutions to AAV's redosing problem, which could reignite industry interest in a modality that has fallen out of favor, and other topics in the spotlight at this week's American Society of Gene and Cell Therapy annual meeting. The analysts also discuss opportunities to attend and present academic posters at the third BioCentury Grand Rounds U.S. conference June 3-5 in Seattle. This episode of the BioCentury This Week podcast has been brought to you by Jeito Capital.View full story: https://www.biocentury.com/article/659426#FDA #GeneTherapy #AAV #CellTherapy #Biopharma00:01 - Sponsor Message: Jeito Capital01:43 - Bio€quity Europe Prague Highlights04:54 - Makary on Thin Ice14:37 - Grand Rounds Poster Pitch16:40 - AAVs at ASGCTTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Joyce talks about:Virginia Rep. Jen Kiggans called to resign after agreeing with "Cotton picking hands," comment said about Minority Leader Hakeem Jeffries.CNN reports on details of sexual violence during the October 7th massacre. FDA Administrator Dr. Marty Makary stepping down after 13 months. Rumors say he clashed over rushes to get vaccines and vaping approvals. AG Todd Blanche warns anyone who may leak government secrets will face prosecution. Inflation on the rise.Politics and political games on both sides. Moderna flu trials risk vs benefit. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In our news wrap Tuesday, FDA head Marty Makary is resigning after an uneven tenure at the agency, UK Prime Minister Keir Starmer is refusing to resign despite growing pressure from within his own party, and FBI Director Kash Patel pushed back against accusations that he drinks to excess on the job and is at times unreachable by his staff. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Dr. Jonathan Howard (neurologist and author) and science journalist Wendy Orent return for another sharp, unsparing look at the state of U.S. public health policy. In this episode, the hosts unpack the surprise withdrawal of Casey Means as surgeon general nominee, her replacement by Fox News commentator and MSKCC breast imaging chief Dr. Nicole Saphier, and what the shuffle signals about the fracturing of the MAHA coalition. They dig into Saphier's contradictory record — pro-vaccine statements from 2020 and 2021 set against more recent anti-vaccine messaging, her supplement business (DropRx), and her now-deleted social media posts criticizing Trump and Elon Musk. From there, the conversation turns to the FDA's blocked publication of research showing the COVID and shingles vaccines are safe, the apparent role of former FDA vaccine office chief Dr. Vinay Prasad, and reporting that FDA Commissioner Marty Makary's job is in jeopardy. The episode also covers a small piece of good news — NIH program director Jenna Norton being reinstated after Jay Bhattacharya placed her on administrative leave for organizing the Bethesda Declaration — alongside disturbing developments: RFK Jr. clearing the path for minors to use tanning beds, and the militarized arrest of 78-year-old retired NIH scientist Dr. David Morens. Howard and Orent close on what the Morens arrest reveals about where lab leak conspiracy thinking has led American science and the rule of law. Hosts Dr. Jonathan Howard: Neurologist, professor, and author who writes prolifically on COVID misinformation and public health policy. Wendy Orent: Science journalist and author specializing in infectious disease, evolutionary biology, and public health. Episode Timestamps [00:00] Welcome and Atlanta weather check-in [00:35] Casey Means out, Nicole Saphier in as surgeon general nominee — what it signals about MAHA [01:30] Saphier's role at Memorial Sloan Kettering and her integrative medicine push [02:50] The 2021 WSJ op-ed with Marty Makary: a 10-fold error on pediatric COVID hospitalizations that was never corrected [06:30] Saphier's video opposing COVID vaccines for healthy children — and the framing of myocarditis as a fate worse than death [09:20] Saphier's earlier pro-vaccine statements from 2020 and 2021, and why MAHA now resents her [11:15] DropRx supplements: the surgeon general nominee's tincture business [12:30] Brandy Zadrozny's reporting on Saphier's book and her past criticism of the Plandemic film [13:10] Wendy watches Plandemic so you don't have to: Judy Mikovits and the anti-vaccine machine [14:50] CNN reports Saphier purged posts critical of Trump and Musk before her nomination [15:50] The most disturbing Saphier clip: 'DOGE is one of the greatest things to happen in U.S. history' while telling cancer researchers to 'just pause' [16:50] Harvard's November 2025 finding: hundreds of thousands of deaths from the USAID shutdown [18:20] Good news: Jenna Norton reinstated at NIH after Jay Bhattacharya tried to fire her over the Bethesda Declaration [19:30] Greg Gonsalves on scientists who cooperate with authoritarian science policy [20:10] FDA blocked publication of research showing the COVID and shingles vaccines are safe [21:30] Vinay Prasad: the censorship critic who became a censor [22:30] Why are these people opposed to the shingles vaccine? Howard and Orent on herpes zoster, strokes, and ophthalmic complications [23:50] New evidence: recombinant zoster vaccine linked to reduced dementia risk in adults 65+ [26:10] Marty Makary's FDA in chaos — WSJ, Bloomberg, and Politico reporting on a possible shakeup [28:00] Trump pressures the FDA to approve flavored vapes; ENDS authorization issued the same day [31:00] Makary's interview defending the Replimmune metastatic melanoma rejection — and getting caught in the contradiction [33:30] Who's really driving the FDA shakeup? Biotech investors, not patients [35:30] RFK Jr. clears path for minors to use tanning beds, and what dermatologists are saying [36:30] The arrest of Dr. David Morens: a 78-year-old retired NIH scientist, federal agents, tactical gear, and a strip-search [38:30] Lysenkoism revisited — what the lab leak conspiracy was always going to lead to [40:30] Closing thoughts and sign-off Key Discussion Points The Nicole Saphier Nomination Casey Means was withdrawn as surgeon general nominee and replaced by Dr. Nicole Saphier, head of breast imaging at Memorial Sloan Kettering Cancer Center and a frequent Fox News medical commentator. Howard revisits Saphier's December 2021 Wall Street Journal op-ed with Marty Makary, which understated pediatric COVID-19 hospitalizations by roughly a factor of 10 because the authors did not realize covid.net data only covered about 10 percent of the U.S. population. The error has never been corrected. Saphier's pre-nomination digital footprint included pro-vaccine statements from 2020 and 2021 alongside more recent anti-vaccine content, criticism of Trump and Elon Musk that has since been purged, and a personal supplement line called DropRx. FDA Censorship of Vaccine Safety Research The FDA blocked publication of internal research finding that the COVID-19 and shingles vaccines are safe, with reporting suggesting Dr. Vinay Prasad's office was involved in the decision before he left the agency. Howard points out the irony: Prasad built much of his public profile complaining about scientific censorship, then engaged in censorship the moment he held FDA power. New peer-reviewed research continues to show the recombinant zoster (shingles) vaccine is associated with reduced dementia risk in adults aged 65 and older, even as senior officials downplay or block such findings. Marty Makary on Thin Ice Multiple outlets — the Wall Street Journal, Bloomberg, NOTUS, and a Rachel Bade scoop — report Makary is at risk of being removed as FDA Commissioner over conflicts with the White House and his handling of rare-disease drug approvals. The same day Trump publicly pressured the FDA on flavored vapes, the agency issued a press release authorizing new ENDS (electronic nicotine delivery systems) products. In a 15-minute interview, Makary defended the rejection of Replimmune's metastatic melanoma drug by attributing it to career FDA scientists, but the journalist surfaced earlier indications that the initial review team had recommended approval. A Rare Piece of Good News NIH program director Jenna Norton, a key organizer of the Bethesda Declaration, was reinstated after Dr. Jay Bhattacharya placed her on administrative leave. A judge also reinstated several FEMA employees in the same ruling. The Arrest of Dr. David Morens Federal agents in tactical gear and bulletproof vests arrested Dr. David Morens, a 78-year-old retired NIH influenza researcher and former aide to Dr. Anthony Fauci, at his home over allegations he used a private email account to discuss official business and avoid FOIA disclosure. According to reporting in Science, Morens was strip-searched, handcuffed, and driven roughly 65 kilometers for fingerprinting and booking. Howard and Orent frame the arrest as the predictable endpoint of years of lab leak conspiracy rhetoric, and as a clear case of selective political prosecution. Mentioned in This Episode Wall Street Journal op-ed: 'Should You Vaccinate Your Five-Year-Old?' by Nicole Saphier and Marty Makary, December 3, 2021 Plandemic (2020 anti-vaccine film featuring Judy Mikovits) Make America Healthy Again (book by Nicole Saphier) Harvard study, November 2025, on deaths attributable to the USAID shutdown Greg Gonsalves essay on Vichy scientists Bethesda Declaration Alyssa Finley, Wall Street Journal: 'President Trump's Marty Makary Problem' Bloomberg: 'Paranoia, Turmoil and Backlash Inside Marty Makary's FDA' Rachel Bade: 'Scoop: Makary's Job in Jeopardy as White House Considers FDA Shakeup' Liz Esely White, Wall Street Journal: 'Trump Pressures FDA Commissioner to Approve Flavored Vapes' Los Angeles Times: 'RFK Jr. clears path for minors' use of tanning beds, much to the dismay of dermatologists' Science: 'Guns and bulletproof vests: How federal agents arrested a Fauci aide' Brandy Zadrozny — reporting on Nicole Saphier

Howie Kurtz on recent reporting that FDA commissioner Marty Makary was about to be booted out, President Trump fueling debate over who will succeed him, and the President increasing his attacks on TV networks. Learn more about your ad choices. Visit podcastchoices.com/adchoices

President Trump has rejected Iran's counteroffer in the effort to end the war. In the UAE, CNBC's Dan Murphy reports on the negotiations and the energy prices hanging in the balance. In Beijing, CNBC's Eunice Yoon awaits the arrival of President Trump–and tech leaders–for a meeting with President Xi. In the U.S., hantavirus patients have arrived in Nebraska. Former FDA Commissioner Dr. Scott Gottlieb discusses the risks of the illness, as well as the rumored potential departure of current FDA commissioner Dr. Marty Makary. Ed Yardeni discusses the market records, despite geopolitical headwinds.    Dan Murphy - 04:28 Eunice Yoon - 12:58 Ed Yardeni - 19:00 Dr. Scott Gottlieb - 35:30    In this episode: Eunice Yoon, @onlyyoontv Dan Murphy, @dan_murphy Joe Kernen, @JoeSquawk Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin Katie Kramer, @Kramer_Katie Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Mary-Simone Collazo delivers the news on UFO files released by the Pentagon, ABC accusing the FCC of violating free speech rights, and President Trump planning to remove FDA commissioner Dr. Marty Makary, on 05/09/2026.

Peter Mantas returns to the show. This is a follow up episode to the episode discussing uniQure. It's timely given the amount of media attention Marty Makary is getting; in part because of uniQure. Describing his trip on his Substack: "I flew to Washington D.C. on Friday (and drove to Baltimore on Saturday) with a thesis. I left with something harder to quantify, not a different thesis exactly, but a materially deeper understanding of the terrain on which this thesis will ultimately be resolved, and a set of experiences that I think are worth documenting carefully, both for subscribers who are following AMT-130 and for anyone who wants to understand what is actually at stake in this regulatory fight."We hope you find the episode interesting and informative.Sponsorship InformationThank you to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fiscal.ai⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for sponsoring the show. DISCOUNT INFO: If you use the affiliate link ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠fiscal.ai/brew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, you will automatically get 2 weeks of Fiscal Pro for Free and if you find that you want to upgrade, my link will get you 15% off any paid plans. About ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fiscal.ai⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fiscal.ai⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ is the complete modern data terminal for global equities.The ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fiscal.ai⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ platform combines a powerful user experience with all the financial data capabilities that professional investors need. Users get up to 20 years of historical financials for all stocks globally that they can easily chart, compare, or export into their own models. And unlike legacy data terminals where it can take hours or even days, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fiscal.ai⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠'s data is updated within minutes of earnings reports. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fiscal.ai⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ also tracks all the company-specific Segment & KPI data so you don't have to. Like to track Amazon's Cloud Revenue? They've got it.How about Spotify's premium subscribers? Or Google's quarterly paid clicks?They've got all of it.

FDA Commissioner Dr. Marty Makary discusses President Trump's Executive Order aimed at faster research and access to psychedelics, citing promising research and calling this an 'historic moment.' He talks with Romaine Bostick and Katie Greifeld on "The Close."See omnystudio.com/listener for privacy information.

Jordan Sather and Nate Prince are back from a week off and wasting no time. Trump has nominated Dr. Erica Schwartz as the new CDC director, and the MAHA world is already split on whether that's a win or a wolf in sheep's clothing. Kennedy is deregulating a list of peptides that had been quietly shoved into an FDA regulatory black hole since 2023, which means your BPC-157 can finally breathe again. The USDA is spending $60 million on real food for Americans (yes, actual fruit and chicken, not Froot Loops), and Joel Salatin is out here pitching Trump a "food emancipation proclamation." Meanwhile, cracks are showing inside the MAHA coalition as Dr. Malone takes aim at both RFK Jr. and FDA chief Marty Makary. It is a full plate of wins, drama, and cautious optimism from your favorite health freedom news desk.

Stacey Richter interviews neurosurgeon Dr. Ahilan Sivaganesan (Dr. Siva) about replacing vague healthcare "value" claims with quantified outcomes and unit-level costs, introducing his Operative Value Index (OVI). They discuss how hospitals often lack true internal episode costs and how common quality metrics miss patient-reported outcomes and appropriateness across the full care journey.  Using time-driven activity-based costing (TDABC) and condition- or procedure-specific patient-reported outcomes, OVI creates a common mathematical language to compare surgeons, practices, or health systems, risk-adjust for confounders, and support steering/tiering and direct contracting for self-funded employers.   Siva describes transparency via bubble charts that spur clinician behavior change without new incentives and argues this infrastructure is essential as bundled payments and risk-based arrangements expand, framing a "Yahoo vs Google" shift from fee-for-service volume to measurable value.  === LINKS ===

FDA Commissioner Dr. Marty Makary convenes top researchers to confront the surge in food allergies, warning past medical advice to avoid allergens helped fuel today's crisis - and then joins AM Update for an exclusive interview. Dr. Casey Means tells senators America is the world's most chronically ill wealthy nation, arguing public health must target root causes, not just treatment at her confirmation hearing for Surgeon General. Bill Gates admits his relationship with Jeffrey Epstein was a “huge mistake,” saying he saw nothing illegal but acknowledging the association cast a shadow over his foundation. New polling shows Congresswoman Jasmine Crockett surging ahead in the Texas Democrat Senate primary as turnout rises and the race enters its final days.   PureTalk: Tired of big wireless prices? Switch to PureTalk for unlimited talk and text for $25/month—dial #250 and say MEGYN KELLY for 50% off your first month.   Herald Group: Learn more at https://GuardYourCard.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.